March 2017, Volume 67, Issue 3

Original Article

Diagnostic dilemma of granulomatous inflammation in cancer patients

Azizullah Khan Dhiloo  ( Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan. )
Aun Raza  ( Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan. )
Naseem Akhtar  ( Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan. )
Waleed Zafar  ( Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan. )
Faisal Sultan  ( Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan. )


Objectives: To determine the frequency of granulomatous inflammation on histopathological findings amongst cancer patients and correlating them with tuberculosis.
Methods: The retrospective review was conducted at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, and comprised medical records of cancer patients with a histopathological finding of granulomatous inflammation between January 2010 and December 2015. Data was reviewed, including clinical history, availability of acid fast bacilli stain on tissue and mycobacterium tuberculosis culture results. Data related to treatment, duration and outcomes was also reviewed and was analysed using SPSS 19.
Results: Out of 28690 cancer patients during the study period, 17345(60.4%) had undergone biopsy for different reasons, and of those, 78 (0.45%) had granulomatous inflammation and formed the study sample. Among them, 40(51.3%) patients had caseous granulomatous inflammation while 38 (48.7%) had non-caseous granulomas. Acid fast bacillus tissue stain was performed on 77(98.7%) patients, of whom only 9 (11.5%) specimens showed acid fast bacilli. Mycobacterium tuberculosis culture was performed on 53(68%) specimens and among them 13(16.7%) grew mycobacterium tuberculosis. Anti-tuberculosis treatment was offered to 38 (48.7%) patients, including those with positive AFB stain and MTB culture results. Of them, 32(41%) patients completed the treatment while 4(5.1%) defaulted and 2(2.6%) died. Symptomatic and radiological improvement was observed in 16(20.5%) patients.
Conclusion: Granulomatous inflammation was infrequently encountered in cancer patients. Mycobacterium tuberculosis cultures assisted in definitive decision-making but granulomatous inflammation could not be anticipated when the specimens were initially processed except when visible caseation was encountered. Processing specimens for mycobacterium tuberculosis cultures when caseation was encountered may be a reasonable strategy to adopt.
Keywords: Granulomatous inflammation, Cancer, Tuberculosis. (JPMA 67: 405; 2017)


Pakistan ranks fifth amongst high tuberculosis (TB) burden countries worldwide. It accounts for 61% of the TB burden in the World Health Organisation (WHO) Eastern Mediterranean Region.1
A progressive rise in the prevalence of cancer has been seen all over the world with an expected 20 million new cases to be added per year by 2020 with approximately 50% of cases emerging from the developing countries.2
In a high-burden country, coexistence of TB with other diseases is not surprising, especially conditions that may contribute to immunosuppression. The presence of granulomatous inflammation in biopsy specimens in cancer patients therefore presents a dilemma because most of the time it is a finding on histopathological studies done during the diagnostic work-up and staging of the suspected malignancy. Lungs are the most common site of infection in TB, but extra-pulmonary disease is becoming more prevalent.3 Granuloma, the histopathological hallmark of mycobacterium tuberculosis (MTB)infection, represents both an immunological and physical barrier meant to contain the infection. Poor granuloma structure is also known to be associated with disseminated disease.4
Currently, limited data is available on the prevalence of TB among cancer patients, especially from Pakistan. Hence, the current study was planned to identify patients with granulomatous inflammation on histopathological findings and correlating them with TB.

Materials and Methods

The retrospective review was conducted at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, and comprised medical records of cancer patients with a histopathological finding of granulomatous inflammation between January 2010 and December 2015. Data was retrieved after approval by the institutional review board. All those over the age of 18 years were deemed to be adults. Patient\\\'s demographics, histopathological findings, availability of MTB culture, treatment and outcome were reviewed. Patients with incomplete history and those who were lost to follow-up were excluded. Data was collected on a pre-designed proforma after extraction from the hospital information system and entered into SPSS 19 for further analysis. Standard descriptive summary statistics were used to characterise the sample of patients.


A total of 28690 cancer patients were registered over the study period and 17345(60.4%) had biopsies done for cancer diagnosis or staging work-up, and among them 78(0.45%) were identified with granulomatous inflammation on histopathology who formed the study sample. Among them, 10 (12.8%) patients were in the paediatric age group (< 18 years) with a mean age of 10.90±4.43 years. The remaining 68 (87.2%) were adults with a mean age of 48.74±13.43. There was a female predominance with 53(68%) females in the sample. Breast cancer was the most common 25(32%) followed by gastrointestinal malignancies 16(20.5%) (Table-1).

A majority of the specimens were from lymph nodes 49(62.8%) followed by specimens obtained from lung tissue and pleura 17(21.8%). Caseating granulomatous inflammation was found in 40(51.3%) patients and non-caseous granulomas were found in 38(48.7%). There were 7(9%) patients with history of chronic fever and 21(26.9%) with chronic cough. Weight-loss when documented was not clearly ascribable to either TB or existing malignancy. A history of contact with a person with active TB was found to be present in 5(6.4%) cases only and 6(7.7%) cases had history of previous TB treatment (Table-2).

Comparison between histopathology, malignancy type and treatment with anti-tuberculosis treatment (ATT) was also done (Table-3).

Among patients with granulomatous inflammation, acid fast bacilli (AFB) stain was performed in 77(98.7%) patients and was found to be positive among 9 (11.5%). MTB culture was performed in 53(68%) patients and was found positive in 13(16.7%).
Patients with suggestive symptoms and signs, consistent radiological findings and caseous necrosis, those having positive AFB stain or MTB cultures were clinically deemed to be TB. There were 38(48.7%) such patients and they were started on ATT. Of them, 32(41%) completed the treatment, 4(5.1%) defaulted and 2 (2.6%) died. Symptomatically, 7(9%) patients with cough and fever were treated and showed full recovery. Cervical lymphadenopathy reduced in size in 3(3.8%), weight-gain was documented in 3(3.8%) and 1(1.3%) patient\\\'s lung infiltrates resolved with treatment. The rest of the treated patients did not have constitutional symptoms or radiological changes at the start of the treatment so clinical or radiological improvement could not be documented. Overall, 40(51.3%) patients were not treated for TB and received diagnosis and stage-appropriate treatment without any dose or regimen modification from the oncology service.


About one-third of world\\\'s population is infected with TB and less than 10% develop active TB. The remaining individuals with latent TB act as a reservoir of mycobacterium bacillus and can develop disease when their immunity wanes. Patients with compromised cellular immunity like those with lymphoproliferative disorders, transplant recipients and on immunosuppressive therapy are at particular risk for TB.5 Chemotherapy for cancer in these patients can lead to development of TB if a pre-existing granuloma contains viable organisms.
In a country with high TB prevalence, the clinical diagnosis of TB amongst cancer patients can be challenging. Relationships between granulomatosis and cancers have been suspected for a long time,6 yet TB and cancer can co-exist, creating diagnostic dilemmas due to similarities in presentation leading to delay in the diagnosis and appropriate therapy.2,7
A granuloma is an organised structure consisting of highly differentiated cells such as multi-nucleated giant cells, epithelioid cells and foamy cells surrounded by lymphocytes. It is the main feature of immune response and serves to contain infection, but some of the bacilli survive inside the granuloma and remain dormant for months or years. Once the immune system of an individual is weakened, these bacilli may escape the granuloma, reactivate and result in clinical disease.8
Granulomatous inflammation can be found in many conditions other than TB like sarcoidosis, fungal infections, histoplasmosis, leprosy, non-tuberculous mycobacteria, actinomycosis and non-infectious conditions like Crohn\\\'s disease, polyangiitis with granulomatosis, foreign body and Langerhan cell histiocytosis.
Confirmation of mycobacterial infection as a cause of granulomatous inflammation requires either culture or molecular tests. When these are not available or not ordered initially, morphological features on histopathology and stains for fungus and TB become the mainstay of diagnosis. But among cancer patients, diagnosing TB and other granulomatous diseases becomes a major challenge as granuloma can be a feature of malignancy itself. Tumour related sarcoid reactions occur with an average frequency of 4% in carcinoma, 7% in non-Hodgkin\\\'s lymphoma and 14% in Hodgkin\\\'s disease.9 Difficulties in interpretation may lead to inappropriate treatment of either malignancy or granulomatous disease.
To our knowledge, no studies have been performed on the prevalence of granulomatous inflammation among cancer patients in Pakistan, though a number of studies suggest that signs of granulomatous inflammation are likely to mimic malignancy like granulomatous mastitis mimicking breast cancer, and aspergillus infection mimicking disseminated lung cancer.10-12 At other times diagnosis of a granulomatous reaction has been assumed as a benign cause and lead to a misdiagnosis of a malignant process presenting subsequently with disseminated malignancy with a grave prognosis.13
In our study, total of 28690 cancer patients were registered during a 6-year period, and out of them 17345 patients underwent biopsy, 78 (0.45%) had finding of granulomatous inflammation. Majority of granulomatous inflammation was found on biopsies done for staging work-up, but this finding was also noticed on initial biopsies. A majority of our patients comprised adult women, which is due to the fact that breast samples make up a large proportion of our studied samples.
Among 78 patients with granulomatous inflammation, we treated 38 (48.7%) for TB. Most of these patients did not have prior clinical symptoms of TB. Additionally, suspecting and diagnosing TB among cancer patients is a challenge since TB and cancer share similar presenting symptoms of fever, weight-loss, anorexia, night sweats and other systemic symptoms.
AFB stain was performed on 77 (98.7%) while MTB culture was performed on 53 (68%) subjects. MTB cultures or molecular tests were not performed on all these tissue biopsies since TB was not considered a differential in most of these patients at the time of their presentation to hospital, owing to a prior assumption of malignancy.
Granulomatous inflammation was an alarming finding and patients were referred to the infectious diseases clinic to rule out co-existent TB. The majority 68(87.2 %) had negative AFB stain while 9 (11.5%) were stain-positive cases. MTB culture was performed on 53 (68%) specimens and yielded MTB in 13(16.7%). This finding was consistent with other studies as diagnostic yield of AFB stain and MTB culture both is low from histopathological specimens showing 3.9% sensitivity for conventional AFB staining and no cases were detected by conventional MTB culture in one of the studies comparing various tests for diagnosis of extra-pulmonary TB.14
In our study, necrotising granulomatous inflammation was found among 40(51.3%) subjects and this appeared to be an important factor in deciding treatment for TB. Because of low culture yield for TB on histopathological specimens, caseating granulomas on histopathology, AFB and fungal stains, cytology, immunostaining and response to ATT were used to differentiate between infection and malignancy in our study.
Among culture-proven TB cases, majority were pan-sensitive, only 2 subjects had isoniazid and pyrazinamide mono resistance and only one had multidrug resistant (MDR) TB. The results appear to be little different compared to other studies showing 17% MDR cases from extra-pulmonary sites in one of the previous studies from Pakistan.15
Due to the background high prevalence of TB in our country, a history of TB exposure is not infrequently encountered and therefore is less helpful than what may be the situation in a low-prevalence country. Our study demonstrates a history of contact being present in only 5 (6.4%) cases.
A total of 38(48.71%) patients were treated for TB; 32(84.21%) completed the treatment, 4(10.52%) defaulted and 2 (5.2%) died. We could not define bacteriological cure in our study as the diagnosis of TB was considered from biopsy specimens, which is also mentioned in another study.15


Co-existence of granulomatous inflammation and malignancy was uncommon. Although the presence of caseating granuloma is a hall mark of TB, but it is not a specific one. It is difficult to confirm the presence of TB among cancer patients solely on the basis of histopathology and AFB stain findings. We recommend that when granulomatous inflammation is suspected, or when visible caseation is encountered surgically, the sample should also be submitted in appropriate medium for processing in the microbiology laboratory for MTB culture studies in addition to histopathological review.
Disclaimer: None.
Conflict of Interest: None.
Funding Disclosure: None.


1. World health organization. The global plan to stop TB 2011-2015; transforming the fight towards elimination of tuberculosis.
2. Sharma V, Kerr SH, Kawar Z, Kerr DJ. Challenges of cancer control in developing countries: current status and future perspective. Future Oncol. 2011; 7: 1213-22.
3. Jana N, Mukhopadhyay S, Dhali GK. Pelvic tuberculosis with elevated serum CA125: a diagnostic dilemma. J Obstet Gynaecol. 2007; 27: 217-8.
4. Emile JF, Patey N, Altare F, Lamhamedi S, Brousse N, Casanova JL, et al. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol.1997; 181: 25-30.
5. Silva FA, Matos JO, de Q Mello FC, Nucci M. Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. Haematologica. 2005; 90:1110-5.
6. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J RespirCrit Care Med. 1999; 160: 1668-72.
7. García CM, Ruiz JP, Sánchez-Martínez JA, Delgado-Martín AE, Amzouz AA, Quero JH. Concomitant tuberculosis and lung cancer diagnosed by bronchoscopy. Int J Tuberc Lung Dis. 2015; 19: 1027-32.
8. Adams DO. The granulomatous inflammatory response. A review. Am J Pathol. 1976; 84: 164-191.
9. Brincker H. Sarcoid reactions in malignant tumors. Cancer Treat Rev. 1986; 13: 147-56.
10. Mohammed S, Statz A, Lacross JS, Lassinger BK, Contreras A, Gutierrez C, et al. Granulomatous mastitis: a 10 year experience from a large inner city county hospital.JSurg Res. 2013; 184: 299-303.
11. Stern JB, Wyplosz B, Validire P, Angoulvant A, Fregeville A, Caliandro R, et al.Bulky mediastinal aspergillosis mimicking cancer in an immunocompetent patient..Ann ThoracSurg. 2014; 98: 1472-5.
12. Imtiaz S, Siddiqui N, Ahmad M, Jahan A. Pelvic-peritoneal tuberculosis mimicking ovarian cancer. J Coll Phys Surg Pak. 2012; 22: 113-5.
13. Wei H, Hou J, Pan J, Su X, Li L, Wang X, et al. A sarcoidosis-like granuloma reaction in the lymph nodes of a patient with lung squamous cancer: from stasis to the invasive phase with FGFR1 gene amplification. Clin Respir J. 2016; 10:530-4.
14. Chakravorty S, Sen KM, TyagiSJ. Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology. J ClinMicrobiol. 2005; 43: 4357-62.
15. Chandir S, Hussain H, Salahuddin N, Amir M, Ali F, Lotia I, et al. Extrapulmonary tuberculosis: a retrospective review of 194 cases at a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc. 2010; 60: 105-9.

Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: